What is the diagnostic approach for thalassemia?

Diagnostic Approach for Thalassemia

Thalassemia diagnosis requires a three-tiered approach: complete blood count showing microcytic hypochromic anemia, hemoglobin analysis by HPLC or capillary electrophoresis, and molecular DNA testing to identify specific globin gene mutations. 1

Initial Screening: Hematologic Parameters

• Obtain a complete blood count (CBC) as the primary screening tool, looking specifically for microcytosis (low MCV) and decreased hemoglobin content of red blood cells, which are hallmarks of all thalassemic conditions 2
• Note that these red blood cell indices alone cannot discriminate between thalassemia trait and iron deficiency, nor between α- and β-thalassemia variants 2
• Patients with rare mutations (HBA2:c.34A>C, HBA1:c.354_355insATC, HBB:c.170G>A) may not exhibit typical microcytic hypochromia, making hemoglobin analysis essential even with normal CBC results 3

Second-Tier Testing: Hemoglobin Analysis

• Perform hemoglobin analysis using either high-performance liquid chromatography (HPLC) or capillary zone electrophoresis (CE) for both qualitative and quantitative assessment of hemoglobin components 2
• Both systems provide good correlation, but interpretation under CE requires caution because Hb A2 is clearly separated from Hb E, and α-thalassemia gene interactions can affect the amount of Hb A2/E 2
• These protein-based techniques are frequently adequate for initial diagnosis and can support prenatal and postnatal diagnoses within a short period 2, 4

Definitive Diagnosis: Molecular Testing

Molecular DNA analysis is required for definitive diagnosis, particularly when protein-based techniques yield uncertain results, for genetic counseling, and for prenatal/preimplantation genetic diagnosis. 1, 5

Molecular Testing Options:

• Traditional PCR-based methods can detect common point mutations in β-thalassemia and large deletions in α-thalassemia, but have limitations with rare variants and complex genetics 2, 6

• Next-generation sequencing (NGS) offers superior accuracy for variant calling with lower error rates and can detect mutations that may be misdiagnosed by conventional techniques 2, 6

• Third-generation sequencing (TGS), particularly accurate circular consensus long-read sequencing, demonstrates the highest detection rate:

  • TGS showed a 5.04% higher detection rate compared to PCR-based methods (68.91% vs. 63.87%) 3
  • Detected an additional 17.67% of clinically significant rare thalassemia variants missed by traditional screening 7
  • Can identify rare HBA1/2 mutations (--THAI, HBA2:c.34A>C, HBA1:c.354_355insATC), rare compound mutations, and rare triplicates of α-globin variants in a single assay 3
  • Confirms cis/trans configuration of allelic gene mutations in one step 3
  • Superior for variant discovery on homologous genes and CNV calling due to longer read lengths 6

Clinical Classification Context

• Classify patients as transfusion-dependent thalassemia (TDT) if they require regular blood transfusions to survive, or non-transfusion-dependent thalassemia (NTDT) if they do not 1
• This classification has replaced older terminology of "thalassemia major" or "thalassemia intermedia" and embraces all forms including α-thalassemia, hemoglobin E/β-thalassemia, and combined α- and β-thalassemias 1

Critical Pitfalls to Avoid

• Do not rely solely on CBC results, as rare thalassemia variants may present with normal or atypical hematologic parameters 3
• Always perform both blood routine tests and hemoglobin electrophoresis combined with molecular testing to minimize missed or incorrect diagnoses 3
• Be aware that coincident α-thalassemia in patients with β-thalassemia may be difficult to diagnose using standard techniques, which can have serious consequences for genetic counseling 4
• Unusual forms of β-thalassemia caused by deletions in the β-globin locus cannot be definitively characterized using standard protein-based techniques alone 4

Practical Implementation

For laboratories transitioning to advanced molecular diagnostics, select the technique most familiar and economically feasible for routine use 2. While TGS is currently more expensive, it provides the most comprehensive approach for thalassemia screening and clinical diagnosis, particularly for rare variants 3. As sequencing costs decrease, TGS will become increasingly applicable for widespread genetic disease screening 3.